Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
about
Genomic Plasticity of the Human Fungal Pathogen Candida albicansTreatment of murine disseminated candidiasis with L-743,872A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida kruseiIn vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infectionMultiple efflux mechanisms are involved in Candida albicans fluconazole resistanceSpecies distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasisComparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.In vitro activity of a new polyene, SPA-S-843, against yeasts.Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.Oropharyngeal candidiasis in the era of antiretroviral therapyAntifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.Role of newer azoles in surgical patients.Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisElevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episodePiperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole.Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans.Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafineUPC2 is universally essential for azole antifungal resistance in Candida albicans.Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method.Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis.Population structure and properties of Candida albicans, as determined by multilocus sequence typing.Approaches to fungal diagnosis in transplantation.In vitro antifungal susceptibility testing.Antifungal resistance among Candida species.Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest EthiopiaInterpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingGenome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicansPharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis
P2860
Q21999033-A5E0D11C-9CE4-47DD-9B31-BB4251CA3E83Q28379078-62F10655-46EB-4CEB-8B2E-036205DB3C74Q28379227-9FA16997-FB47-4FF6-B6BD-2A2A418866F1Q28379496-ED942E98-140B-4BE7-8F75-27847EBDAD9CQ28379619-A9048C41-E213-40EB-A913-D8EE9CCE8193Q33359301-2095143F-ECC6-4CE3-946F-C99F04160A94Q33669219-0AE023FB-BCCC-4690-8FA7-41E4CE85A296Q33678068-B8715BFE-FD3B-4B91-9B16-595F1C24CC30Q33679210-940B93E0-C315-4C35-BD59-09AC93B24A09Q33689421-2F5752F7-5CEE-4892-A6D7-10FC76989EF2Q33702041-ACA8E1F1-E741-48A0-80DE-0EF3A5776879Q33721804-ED2AAAE0-3B33-4293-A239-35A28578BF7FQ33746435-A2031639-3A71-45FB-9E57-CF23D82CEE89Q33749111-2D846B8C-D7D9-4BB1-9E81-357ACEDD611FQ33762325-0B27152E-78D5-44AB-A7F9-B7FBA9C91287Q33788619-53610AFC-41FB-4525-81EB-3D46A44CFE22Q33840089-0B932954-021A-4D1E-9EA5-ABC7F3B6E706Q33964121-6B026D48-4C5C-4AE2-BF0B-351EE54BA903Q33967543-F33E6E54-3836-4F83-8227-30E651E77002Q33969896-07B977F5-18D0-4CEE-A72C-7B4B53609F40Q33976044-50D5C39A-9E69-47D5-957F-290D62EC41E9Q33976591-3620F4BF-8733-468A-B22F-F31FDDC5E226Q33978099-350EFABD-3EAF-4221-9DF1-335A893A5BD3Q33978197-74D63D86-784B-4EDB-A796-390306AB658DQ33979398-B85BA532-D1D4-4BDE-81F7-5989E738FC93Q33980741-6A40F8D8-6B65-4050-85CC-95C745D23103Q33992463-2AEE8BAD-DBE6-4FBB-A716-73BA3D860341Q33998030-C00A67D0-68B3-40DE-9882-F7EDA40C88D0Q34057076-2C3AB2A6-138F-43BC-B82A-6A7D44F3D0F4Q34073047-78248237-ACEC-45E2-8B82-57E734DBFB8DQ34142347-DF64B1E3-0793-4D37-A81C-4E9750FAB426Q34143749-657CE8C8-6B4E-446C-AC4C-646FBCA5E58FQ34294880-734ABED3-8B90-42DF-856E-C2F2D790063AQ34335217-E98CCF73-425B-41B9-9BDD-5A764CED33ADQ34335225-A900C13E-D689-43EC-B5F3-91D60F49F297Q34582330-321E5844-3AAF-4F23-BC6E-EEAC3B58C38BQ34647337-E8DEA6FA-F1E6-42B7-BFF8-F1E5E623DA6AQ34887876-C4A0EBB8-C55D-46E5-907D-CBFB01DAED65Q34942381-EC8E7AF1-CDE1-45C8-A797-A3DDA9757D51Q35007030-BD4389BF-E3D6-4CBA-9D2F-335D5A03B722
P2860
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@en
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@nl
type
label
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@en
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@nl
prefLabel
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@en
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@nl
P2093
P356
P1476
Resistance of Candida albicans ...... ting and DNA subtype analysis.
@en
P2093
Farinacci G
Fothergill A
Rhine-Chalberg J
P304
P356
10.1093/CLINIDS/18.2.240
P407
P577
1994-02-01T00:00:00Z